Publications

1P Whole-genome sequencing (WGS) measures of theta-mediated end joining (TMEJ) predict PARP inhibitors (PARPi) benefit

Authors: IG Funingana, J Ambrose, P Smith, T Bradley, L Porcu, AA Sosinsky, JD Brent...

Research group: Brenton Group

E-pub date: 1 Jun 2025

Journal name: ESMO Open

KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage.

Authors: Z Li, G Peluffo, LE Stevens, X Qiu, M Seehawer, A Tawawalla, X-Y Huang, SB ...

Research group: Carroll Group

E-pub date: 1 Jun 2025

Journal name: Nat Genet

CHD8 interacts with BCL11A to induce oncogenic transcription in triple negative breast cancer.

Authors: M Waterhouse, K Lazarus, MF Santolla, S Pensa, E Williams, AJQ Siu, H Moham...

Research group: Carroll Group

E-pub date: 1 Jun 2025

Journal name: EMBO J

Optical control of gene expression using a DNA G-quadruplex targeting reversible photoswitch.

Authors: X Zhang, S Dhir, L Melidis, Y Chen, Z Yu, A Simeone, J Spiegel, S Adhikari,...

Research group: Balasubramanian Group

E-pub date: 1 Jun 2025

Journal name: Nat Chem

A photoswitchable DNA G-quadruplex ligand enables optical control of transcription.

Authors:

Research group: Balasubramanian Group

E-pub date: 1 Jun 2025

Journal name: Nat Chem

Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor.

Authors: J Fares, Y Wan, B Gurung, T Nazar, R Mair, A Joannides, T Santarius, T Maty...

Research group: Mair Group

E-pub date: 1 Jun 2025

Journal name: J Neurooncol

Analysis of event-free survival (EFS) of stromal tumor infiltrating lymphocytes (sTILs), PD-L1 expression, and their early dynamics in the NeoTRIP trial.

Authors: G Bianchini, G Viale, M Dugo, C-S Huang, D Egle, M Callari, H Ali, B Bermej...

Research group: Ali Group

E-pub date: 1 Jun 2025

Journal name: Journal of Clinical Oncology

Why do we continue to have an incomplete understanding of estrogen receptor(s) actions in cancer systems?

Authors: HD McMillan, JS Carroll

Research group: Carroll Group

E-pub date: 1 Jun 2025

Journal name: Endocr Relat Cancer

Filters

Research Groups

Core Facilities

Start date

End date

1P Whole-genome sequencing (WGS) measures of theta-mediated end joining (TMEJ) predict PARP inhibitors (PARPi) benefit

KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage.

CHD8 interacts with BCL11A to induce oncogenic transcription in triple negative breast cancer.

Optical control of gene expression using a DNA G-quadruplex targeting reversible photoswitch.

A photoswitchable DNA G-quadruplex ligand enables optical control of transcription.

Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor.

Analysis of event-free survival (EFS) of stromal tumor infiltrating lymphocytes (sTILs), PD-L1 expression, and their early dynamics in the NeoTRIP trial.

Why do we continue to have an incomplete understanding of estrogen receptor(s) actions in cancer systems?

Themes

Filters

Research Groups

Core Facilities

Start date

End date

1P Whole-genome sequencing (WGS) measures of theta-mediated end joining (TMEJ) predict PARP inhibitors (PARPi) benefit

KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage.

CHD8 interacts with BCL11A to induce oncogenic transcription in triple negative breast cancer.

Optical control of gene expression using a DNA G-quadruplex targeting reversible photoswitch.

A photoswitchable DNA G-quadruplex ligand enables optical control of transcription.

Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor.

Analysis of event-free survival (EFS) of stromal tumor infiltrating lymphocytes (sTILs), PD-L1 expression, and their early dynamics in the NeoTRIP trial.

Why do we continue to have an incomplete understanding of estrogen receptor(s) actions in cancer systems?